Adaptive Biotechnologies's total assets for Q3 2025 were $490.61M, a decrease of -1.21% from the previous quarter. ADPT total liabilities were $286.36M for the fiscal quarter, a -9.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.